U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
187921187921CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) RemissionCompletedNo Results AvailableUlcerative ColitisDrug: OPC-6535|Drug: Asacol®https://ClinicalTrials.gov/show/NCT00092508
187922187922Study of an Investigational Vaccine in Pre-Adolescents and Adolescents (Gardasil)(V501-016)CompletedHas ResultsCervical Cancer|Genital WartsBiological: V501, Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccinehttps://ClinicalTrials.gov/show/NCT00092495
187923187923Immunogenicity Bridge Between an Investigational Monovalent Vaccine and the Equivalent Component of Gardasil (V501) a Quadrivalent Vaccine (V501-012)(COMPLETED)CompletedNo Results AvailableCervical Cancer|Genital WartsBiological: V501, Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine / Duration of Treatment: 4 yearshttps://ClinicalTrials.gov/show/NCT00092482
187924187924Study of an Investigational Vaccine in Healthy Infants in Taiwan (V441-001)(COMPLETED)CompletedNo Results AvailableDiphtheria|Tetanus|Pertussis|Hepatitis B|PoliomyelitisBiological: V441, diptheria, tetanus, acellular pertussis, inactivated poliomyelitis, hepatitis B (recombinant), & Haemophilus influenza type b conjugate vaccinehttps://ClinicalTrials.gov/show/NCT00092469
187925187925Consistency Lots Vaccine Study (V260-009)CompletedHas ResultsRotavirus InfectionsBiological: rotavirus vaccine, live, oral, pentavalent|Biological: Placebohttps://ClinicalTrials.gov/show/NCT00092456
187926187926Dose Confirmation Efficacy Study (V260-007)CompletedHas ResultsRotavirus InfectionsBiological: RotaTeqâ„¢, rotavirus vaccine, live, oral, pentavalent|Biological: Comparator: Placebo matching RotaTeqâ„¢https://ClinicalTrials.gov/show/NCT00092443
187927187927Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016)CompletedNo Results AvailableMeasles|Mumps|Rubella|VaricellaBiological: V221, measles, mumps, rubella and varicella (Oka/Merck) virus vaccine live / Duration of Treatment: 12 weekshttps://ClinicalTrials.gov/show/NCT00092430
187928187928Evaluation of the Safety and Tolerability of a Higher Potency Dose of an Investigational Vaccine Among Adults 50 Years of Age and Older (V211-009)CompletedHas ResultsHealthyBiological: Comparator: Varicella Zoster Virus Vaccine|Biological: Comparator: Varicella Zoster Virus Vaccinehttps://ClinicalTrials.gov/show/NCT00092417
187929187929Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED)CompletedNo Results AvailableMeasles|Mumps|Rubella|VaricellaBiological: measles, mumps, and rubella virus vaccine live|Biological: Comparator: Measles, Mumps, and Rubella Virus Vaccine Livehttps://ClinicalTrials.gov/show/NCT00092404
187930187930A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED)CompletedNo Results AvailableMeasles|Mumps|Rubella|VaricellaBiological: Comparator: M-M-R(TM) II, measles, mumps, and rubella virus vaccine live|Biological: Comparator: VARIVAX(TM) Varicella Virus Vaccine Live (Oka-Merck)https://ClinicalTrials.gov/show/NCT00092391
187931187931A Study of Two Approved Drugs in the Treatment of Post-Bunionectomy Surgery Pain (0966-234)(COMPLETED)CompletedNo Results AvailablePostoperative PainDrug: MK0966, rofecoxib|Drug: Comparator: diclofenac sodium, placebohttps://ClinicalTrials.gov/show/NCT00092378
187932187932A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-220)(COMPLETED)CompletedNo Results AvailableOsteoarthritisDrug: MK0966, rofecoxib|Drug: Comparator: celecoxib, placebohttps://ClinicalTrials.gov/show/NCT00092365
187933187933A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-219)CompletedNo Results AvailableOsteoarthritisDrug: MK0966, rofecoxib|Drug: Comparator: celecoxib, placebohttps://ClinicalTrials.gov/show/NCT00092352
187934187934A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-190)(COMPLETED)CompletedNo Results AvailablePostoperative PainDrug: MK0966, rofecoxib|Drug: Comparator: valdecoxib, placebohttps://ClinicalTrials.gov/show/NCT00092339
187935187935A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-183)CompletedNo Results AvailablePostoperative PainDrug: MK0966, rofecoxib|Drug: Comparator: oxycodone with acetaminophen, placebohttps://ClinicalTrials.gov/show/NCT00092326
187936187936A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-182)CompletedNo Results AvailablePostoperative PainDrug: MK0966, rofecoxib|Drug: Comparator: oxycodone and acetaminophenhttps://ClinicalTrials.gov/show/NCT00092313
187937187937A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-181)(COMPLETED)CompletedNo Results AvailablePostoperative PainDrug: MK0966, rofecoxib|Drug: Comparator: valdecoxibhttps://ClinicalTrials.gov/show/NCT00092300
187938187938Comparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid SyndromeTerminatedNo Results AvailableMalignant Carcinoid SyndromeDrug: lanreotide Autogel (somatostatin analogue)|Drug: Sandostatin long acting release (LAR) Depot (somatostatin analogue)https://ClinicalTrials.gov/show/NCT00092287
187939187939Study of HuMax-CD20, a New Drug to Treat Early Stage Non-Hodgkin´s Follicular LymphomaWithdrawnNo Results AvailableLymphoma, FollicularDrug: HuMax-CD20https://ClinicalTrials.gov/show/NCT00092274
187940187940Factors Determining Outcomes in Patients With Graft-Versus-Host DiseaseRecruitingNo Results AvailableChronic Graft vs Host Diseasehttps://ClinicalTrials.gov/show/NCT00092235
187941187941Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease ActivityRecruitingNo Results AvailableLymphoproliferative Disorder|HHV-8|Malignancy|HIVDrug: Etoposide|Drug: Interferon-alpha|Drug: Rituximab|Drug: Zidovudine|Drug: Liposomal Doxorubicin|Drug: Bortezomib|Drug: Valganciclovir|Drug: Doxorubicin|Drug: Vincristine|Drug: Cyclophosphamide|Drug: Filgrastim (G-CSF)|Drug: Prednisone|Drug: Sirolimushttps://ClinicalTrials.gov/show/NCT00092222
187942187942Antihypertensive Efficacy and Safety of Approved Drugs in Japanese Patients With Essential Hypertension (Banyu Study)(0954A-302)CompletedNo Results AvailableHypertensionDrug: MK0954A, hydrochlorothiazide (+) losartan potassium|Drug: Comparator: placebo, losartan, hydrochlorothiazidehttps://ClinicalTrials.gov/show/NCT00092209
187943187943Study of MK0869 for the Prevention of Chemotherapy-Induced Nausea and Vomiting (0869-071)(COMPLETED)CompletedNo Results AvailableNausea|Vomiting|Breast NeoplasmsDrug: MK0869, aprepitant / Duration of Treatment: 3 dayshttps://ClinicalTrials.gov/show/NCT00092196
187944187944An Investigational Drug for the Prevention of Chemotherapy-Induced Nausea and Vomiting (MK-0869-071)CompletedNo Results AvailableNausea|Vomiting|Breast NeoplasmsDrug: MK0869, aprepitant / Duration of Treatment: 3 days|Drug: Comparator: ondansetron / Duration of Treatment: 3 dayshttps://ClinicalTrials.gov/show/NCT00092183
187945187945An Investigational Agent for the Treatment of Complicated Intra-Abdominal Infections or Acute Pelvic Infections (0826-038)CompletedNo Results AvailableInfections|Pelvic InfectionsDrug: MK0826, ertapenem sodium|Drug: Comparator: Ticarcillin/Clavulanatehttps://ClinicalTrials.gov/show/NCT00092170
187946187946Effectiveness of Two Approved Drugs in Lowering High Cholesterol (0733-224)CompletedNo Results AvailableHypercholesterolemiaDrug: MK0733, simvastatin|Drug: Comparator: simvastatinhttps://ClinicalTrials.gov/show/NCT00092157
187947187947Study of an Approved Drug in Patients With Asthma (0476-289)(COMPLETED)CompletedNo Results AvailableAsthmaDrug: MK0476, montelukast sodium / Duration of Treatment: 4 weeks|Drug: Comparator: placebo / Duration of Treatment: 4 weekshttps://ClinicalTrials.gov/show/NCT00092144
187948187948Montelukast in Exercise-Induced Bronchospasm - 2003 (0476-270)CompletedHas ResultsAsthma, Exercise-InducedDrug: Comparator: Montelukast|Drug: Comparator: Placebohttps://ClinicalTrials.gov/show/NCT00092131
187949187949The Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis (0476-265)CompletedHas ResultsRhinitis, Allergic, PerennialDrug: Montelukast|Drug: Comparator: Placebohttps://ClinicalTrials.gov/show/NCT00092118
187950187950Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256)CompletedNo Results AvailableAsthma, Bronchial|Rhinitis, Allergic, PerennialDrug: MK0476, montelukast sodium|Drug: Comparator: placebohttps://ClinicalTrials.gov/show/NCT00092105

* Görseller ve İçerik tekif hakkına sahip olabilir